Lars Stechemesser
Impact in
- Hepatology top 10%
- Liver Disease and Transplantation
-
- Diet, Metabolism, and Disease
- Diabetes Management and Research
Papers in
-
- Diabetes Management and Research 10
- Diabetes Treatment and Management 7
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 4
- Diabetes Management and Education 3
- Diabetes, Cardiovascular Risks, and Lipoproteins 2
-
- Liver Disease Diagnosis and Treatment 5
- Co-authors
- Elmar Aigner (6 shared papers)Christian Datz (6 shared papers)Bernhard Paulweber (7 shared papers)Alexandra Feldman (5 shared papers)Ursula Huber-Schönauer (5 shared papers)Sebastian K. Eder (3 shared papers)Michael Straßer (4 shared papers)M. Eric Schranz (2 shared papers)
- Journals
- Diabetes & Metabolism (1 paper)BMJ Open (1 paper)Journal of Diabetes Science and Technology (1 paper)Journal of Clinical Medicine (1 paper)Journal of Hepatology (1 paper)
- Partner nations
- AustriaGermanySwitzerland
In The Last Decade
Lars Stechemesser
20 papers receiving 283 citations
Peers
Comparison fields: 5 of 84
- Hepatology 55
- Endocrinology, Diabetes and Metabolism 106
- Epidemiology 134
- Nephrology 15
- Pathology and Forensic Medicine 35
Countries citing papers authored by Lars Stechemesser
This map shows the geographic impact of Lars Stechemesser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Stechemesser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Stechemesser more than expected).
Fields of papers citing papers by Lars Stechemesser
This network shows the impact of papers produced by Lars Stechemesser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Stechemesser. The network helps show where Lars Stechemesser may publish in the future.
Co-authors
The 25 scholars most cited alongside Lars Stechemesser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 91 | |
| 2 | 2015 | 47 | |
| 3 | 2019 | 44 | |
| 4 | 2016 | 32 | |
| 5 | 2018 | 18 | |
| 6 | 2021 | 11 | |
| 7 | 2024 | 7 | |
| 8 | 2019 | 6 | |
| 9 | 2021 | 5 | |
| 10 | 2017 | 5 | |
| 11 | 2020 | 4 | |
| 12 | 2023 | 4 | |
| 13 | 2020 | 2 | |
| 14 | 2016 | 2 | |
| 15 | 2023 | 2 | |
| 16 | 2019 | 1 | |
| 17 | 2012 | 1 | |
| 18 | 2024 | 1 | |
| 19 | 2023 | 1 | |
| 20 | 2018 | 1 |
About Lars Stechemesser
Lars Stechemesser is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology, Surgery, Genetics and Rheumatology, having authored 22 papers that have together received 285 indexed citations. Recurring topics across this work include Diabetes Management and Research (10 papers), Diabetes Treatment and Management (7 papers), Liver Disease Diagnosis and Treatment (5 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (4 papers), Diabetes and associated disorders (4 papers), Diabetes Management and Education (3 papers), Folate and B Vitamins Research (3 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers). The work is most often cited by research in Hepatology (55 citations), Endocrinology, Diabetes and Metabolism (106 citations), Epidemiology (134 citations), Nephrology (15 citations) and Pathology and Forensic Medicine (35 citations). Lars Stechemesser has collaborated with scholars based in Austria, Germany and Switzerland. Frequent co-authors include Elmar Aigner, Christian Datz, Bernhard Paulweber, Alexandra Feldman, Ursula Huber-Schönauer, Sebastian K. Eder, Michael Straßer, M. Eric Schranz, Raimund Weitgasser and Stephan Buch. Their work appears in journals such as Diabetes & Metabolism, BMJ Open, Journal of Diabetes Science and Technology, Journal of Clinical Medicine and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.